## MTD: Mettler-Toledo International, I - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -2.6% below STRENGTH zone (4.0-10.0%); PEG 3.64 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1346.26)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Bank of Nova Scotia Sells 1,719 Shares of Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251211T084908 | Neutral | Relevance: 99%
- Bank of Nova Scotia reduced its stake in Mettler-Toledo International, Inc. by 14.5% during Q2, selling 1,719 shares and holding 10,174 shares valued at $11.95 million. Other institutional investors also adjusted their positions, and company insiders sold shares totaling over $2.1 million in recent transactions. Analysts have issued new price targets and ratings, with the stock currently having an average "Hold" rating and a consensus price target of $1,424.17.

**2. California Public Employees Retirement System Purchases 997 Shares of Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251211T094832 | Neutral | Relevance: 98%
-  The California Public Employees Retirement System increased its stake in Mettler-Toledo International, Inc. by 2.9% in the second quarter, acquiring an additional 997 shares. This brings their total holdings to 35,279 shares, valued at approximately $41.44 million. Other institutional investors have also adjusted their positions, while company insiders like CFO Shawn Vadala and CEO Patrick Kaltenbach have recently sold shares.

**3. The Goldman Sachs Group Begins Coverage on Mettler-Toledo International (NYSE:MTD)**
- Source: MarketBeat | 20251209T133331 | Neutral | Relevance: 98%
-  The Goldman Sachs Group initiated coverage on Mettler-Toledo International (NYSE:MTD) with a "neutral" rating and a $1,475.00 price target, suggesting a potential upside of 6.69% from its current trading price. This new coverage joins other recent analyst reports, resulting in a consensus "Hold" rating and an average target price of $1,424.17 for the medical instruments supplier. Mettler-Toledo International recently reported strong quarterly earnings, beating analyst expectations, and several institutional investors have adjusted their stakes in the company.

**4. Goldman Sachs Initiates Coverage on Mettler-Toledo (MTD) with Ne**
- Source: GuruFocus | 20251209T140824 | Somewhat-Bullish | Relevance: 98%
-  Goldman Sachs has initiated coverage on Mettler-Toledo International Inc. (MTD) with a 'Neutral' rating and a price target of $1,475.00 USD. This report highlights recent analyst activities and forecasts for MTD, noting an average target price of $1,490.41 from 13 analysts, suggesting an upside of 7.89% from its current price. Mettler-Toledo specializes in weighing and precision instruments for life sciences, industrial, and food retail sectors.

**5. Mettler-Toledo International Stock Slides 8.3% With A 8-Day Losing Spree**
- Source: Trefis | 20251209T080829 | Neutral | Relevance: 97%
- Mettler-Toledo International stock has seen an 8.3% decline, marking an eight-day losing streak. The article provides this key financial information regarding the company's recent stock performance.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Goldman Sachs | $1475 | $0 | 0% |
| 2025-12-02 | Morgan Stanley | $1550 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Goldman Sachs | init | Neutral |
| 2025-12-02 | Morgan Stanley | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 18 ($1.28M) |
| Sells | 6 ($0.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+1.4%)
- Blackrock Inc.: 9.2% (-3.1%)
- State Street Corpora: 4.7% (-0.5%)
- Capital Internationa: 4.2% (+1.2%)
- Bank Of New York Mel: 4.0% (-9.0%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.64 signals overvaluation risk, limited margin of safety. Forward P/E 31.1x stretched relative to 8% growth. Quality metrics strong (ROE 30%, ROA 20%, margin 21%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.3B |
| Beta | 1.40 |
| 52W Range | $946.69 - $1525.17 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.64 |
| Forward P/E | 31.1 |
| Current P/E | 33.7 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.8% to -2.6% (+1.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.6pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.6%) - potential reversal signal. Long-term uptrend intact (above SMA200 at 1.14x) but short-term weakness (below SMA20). MACD histogram bearish (-8.93), momentum weakening. RSI neutral at 51.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.61% (CS: 25) | Weak |
| RSI_14 | 50.9 | Neutral |
| MACD Histogram | -8.93 | Bearish |
| vs SMA20 | 0.995x | Below |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 1.142x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1421.58
- **Stop Loss:** $1346.26 (5.3% risk)
- **Target:** $1496.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 18
- **Position Value:** $25,588.44
- **Portfolio %:** 25.59%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-05 (Est: $12.80)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $10.66 | $11.15 | +4.6% |
| 2025Q2 | $9.60 | $10.09 | +5.1% |
| 2025Q1 | $7.88 | $8.19 | +3.9% |
| 2024Q4 | $11.72 | $12.41 | +5.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*